Literature DB >> 12571208

Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer.

Tom R Miller1, Edward Pinkus, Farrokh Dehdashti, Perry W Grigsby.   

Abstract

UNLABELLED: In patients with cervical cancer, it is important to estimate prognosis at the time of diagnosis. This study using PET with (18)F-FDG was undertaken to determine whether a simple and fast visual analysis of characteristics of the primary tumor before initiation of treatment could achieve this goal.
METHODS: Forty-seven patients with cervical cancer who were to be treated by combined radiation therapy and chemotherapy were imaged before beginning treatment. They were then followed for up to 3 y for evidence of recurrence or death. Images of the chest, abdomen, and pelvis were obtained 40-90 min after administration of 370-555 MBq (10-15 mCi) (18)F-FDG. Three observers then independently graded the primary tumor for size (0 = small, 1 = moderate, 2 = large), shape (0 = spherical, 1 = nonspherical), heterogeneity of uptake (0 = none, 1 = moderate, 2 = marked), and presence of lymph nodes (0 = none, 1 = pelvic, 2 = paraaortic, 3 = distant). The scores were summed to achieve a total score. A statistical calculation demonstrated that a score cutoff of 4 best separated patients with a good prognosis from patients with a bad prognosis. Kaplan-Meier analysis was used to compute progression-free survival and overall survival. Evaluation of lymph nodes alone was compared with the grading of tumor characteristics.
RESULTS: Observers 1 and 2 scored 26 patients as having a good prognosis and 21 as having a bad prognosis. Observer 3 scored 30 and 17, respectively, a statistically insignificant difference. Survival curves were almost identical for the 3 observers. For progression-free survival, approximately 12% of patients with a good score had disease recurrence whereas approximately 75% with a bad score had disease recurrence. For overall survival, approximately 10% (good) and 80% (bad) died. Evaluation of lymph nodes also separated the groups, but not as well as did visual analysis alone. The combination of the 2 was only slightly superior to visual assessment alone.
CONCLUSION: A simple, rapid, and highly reproducible system is described for visual grading of characteristics of the primary tumor in patients with cervical cancer at the time of diagnosis. This approach separates patients with a poor prognosis from those who will do well, thus providing a new tool for accurate estimation of prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12571208

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  20 in total

1.  Automatic PET cervical tumor segmentation by combining deep learning and anatomic prior.

Authors:  Liyuan Chen; Chenyang Shen; Zhiguo Zhou; Genevieve Maquilan; Kevin Albuquerque; Michael R Folkert; Jing Wang
Journal:  Phys Med Biol       Date:  2019-04-12       Impact factor: 3.609

2.  Accurate segmenting of cervical tumors in PET imaging based on similarity between adjacent slices.

Authors:  Liyuan Chen; Chenyang Shen; Zhiguo Zhou; Genevieve Maquilan; Kimberly Thomas; Michael R Folkert; Kevin Albuquerque; Jing Wang
Journal:  Comput Biol Med       Date:  2018-04-16       Impact factor: 4.589

3.  Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma.

Authors:  Mathieu Hatt; Florent Tixier; Catherine Cheze Le Rest; Olivier Pradier; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-16       Impact factor: 9.236

4.  In vivo ¹⁸F-FDG tumour uptake measurements in small animals using Cerenkov radiation.

Authors:  Federico Boschi; Laura Calderan; Daniela D'Ambrosio; Mario Marengo; Alberto Fenzi; Riccardo Calandrino; Andrea Sbarbati; Antonello E Spinelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-30       Impact factor: 9.236

5.  Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.

Authors:  Amandine Pallardy; Caroline Bodet-Milin; Aurore Oudoux; Loïc Campion; Emmanuelle Bourbouloux; Christine Sagan; Catherine Ansquer; Aude Testard; Isabelle Resche; Boumédiène Bridji; Françoise Kraeber-Bodéré; Caroline Rousseau
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-20       Impact factor: 9.236

6.  Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors.

Authors:  Stephanie A Harmon; Michael J Tuite; Robert Jeraj
Journal:  Phys Med Biol       Date:  2016-10-03       Impact factor: 3.609

7.  Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography.

Authors:  Jong Doo Lee; Mijin Yun; Jae Myun Lee; Youjeong Choi; Youn-Hee Choi; Ji Su Kim; Se Jong Kim; Kyung Sik Kim; Woo Ick Yang; Young Nyun Park; Kwang-Hyub Han; Woo Jung Lee; Naechun Yoo; Sang Moo Lim; Jeon Han Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-28       Impact factor: 9.236

8.  Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.

Authors:  Mirco Galiè; Paolo Farace; Cristina Nanni; Antonello Spinelli; Elena Nicolato; Federico Boschi; Paolo Magnani; Silvia Trespidi; Valentina Ambrosini; Stefano Fanti; Flavia Merigo; Francesco Osculati; Pasquina Marzola; Andrea Sbarbati
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

9.  The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET/CT.

Authors:  Bum Soo Kim; In Joo Kim; Seong-Jang Kim; Hyun-Yeol Nam; Kyoung June Pak; Keunyoung Kim; Man Soo Yun
Journal:  Nucl Med Mol Imaging       Date:  2010-11-12

10.  Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?

Authors:  Manuel Piñeiro-Fiel; Alexis Moscoso; Lucía Lado-Cacheiro; María Pombo-Pasín; David Rey-Bretal; Noemí Gómez-Lado; Cristina Mondelo-García; Jesús Silva-Rodríguez; Virginia Pubul; Manuel Sánchez; Álvaro Ruibal; Pablo Aguiar
Journal:  Eur Radiol       Date:  2020-11-27       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.